开云app官网登录入口网页版-官方正版

#2型糖尿病患者#

722篇内容 | 5824人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2143582, encodeId=f94b214358262, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>平稳控制血糖，减少并发症的发生, objectTitle=2型糖尿病患者, objectType=topic, longId=1101, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=87, createdTime=2023-06-19, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2143389, encodeId=55092143389d5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>糖尿病，饮食，药物，, objectTitle=2型糖尿病患者, objectType=topic, longId=1101, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=76, createdTime=2023-06-17, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2131004, encodeId=133721310044f, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>学习, objectTitle=2型糖尿病患者, objectType=topic, longId=1101, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=97, createdTime=2023-05-08, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2117964, encodeId=e668211e964e9, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>糖尿病，运动，药物，饮食, objectTitle=2型糖尿病患者, objectType=topic, longId=1101, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=86, createdTime=2023-03-06, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383827, encodeId=a910138382e18, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体, objectType=article, longId=739441, objectId=f6efe39441ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6efe39441ca, replyNumber=0, likeNumber=118, createdTime=2022-09-17, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6efe39441ca, moduleTitle=Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f6efe39441ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383826, encodeId=2dd3138382635, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者累积甘油三酯-葡萄糖指数与主要心血管不良事件的相关性, objectType=article, longId=739207, objectId=3765e39207f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3765e39207f7, replyNumber=0, likeNumber=90, createdTime=2022-09-15, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3765e39207f7, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者累积甘油三酯-葡萄糖指数与主要心血管不良事件的相关性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3765e39207f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383825, encodeId=5fbc138382552, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, objectType=article, longId=739206, objectId=df2ee39206bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2ee39206bd, replyNumber=0, likeNumber=114, createdTime=2022-09-15, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2ee39206bd, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=df2ee39206bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383824, encodeId=4eab138382415, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DRCP：格列美脲/二甲双胍固定联合剂与单药治疗2型糖尿病患者的比较研究, objectType=article, longId=738900, objectId=a718e389006c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a718e389006c, replyNumber=0, likeNumber=77, createdTime=2022-09-12, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a718e389006c, moduleTitle=DRCP：格列美脲/二甲双胍固定联合剂与单药治疗2型糖尿病患者的比较研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a718e389006c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383823, encodeId=b7821383823f6, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Radiology：这些全自动腹部CT指标，实现了2型糖尿病患者的超早期诊断！, objectType=article, longId=737603, objectId=fae9e376032c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fae9e376032c, replyNumber=0, likeNumber=98, createdTime=2022-09-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fae9e376032c, moduleTitle=Radiology：这些全自动腹部CT指标，实现了2型糖尿病患者的超早期诊断！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fae9e376032c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383822, encodeId=8e001383822f5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Front Immunol：维生素D补充剂调节2型糖尿病患者血小板介导的炎症, objectType=article, longId=736726, objectId=8012e3672677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8012e3672677, replyNumber=0, likeNumber=107, createdTime=2022-08-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8012e3672677, moduleTitle=Front Immunol：维生素D补充剂调节2型糖尿病患者血小板介导的炎症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8012e3672677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383821, encodeId=7c65138382193, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Acta Diabetol：降糖药与初级保健的2型糖尿病患者卒中和短暂性脑缺血发作的相关性, objectType=article, longId=736723, objectId=97d7e3672315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97d7e3672315, replyNumber=0, likeNumber=84, createdTime=2022-08-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97d7e3672315, moduleTitle=Acta Diabetol：降糖药与初级保健的2型糖尿病患者卒中和短暂性脑缺血发作的相关性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=97d7e3672315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383820, encodeId=b5871383820fa, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Front Pharmacol：2型糖尿病患者使用DPP-4i、GLP-1 RAs和SGLT-2i的骨折风险, objectType=article, longId=736722, objectId=3a36e36722e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a36e36722e3, replyNumber=0, likeNumber=141, createdTime=2022-08-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a36e36722e3, moduleTitle=Front Pharmacol：2型糖尿病患者使用DPP-4i、GLP-1 RAs和SGLT-2i的骨折风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3a36e36722e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383819, encodeId=95ca138381923, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, objectType=article, longId=736517, objectId=930ce36517e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=930ce36517e1, replyNumber=0, likeNumber=93, createdTime=2022-08-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=930ce36517e1, moduleTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=930ce36517e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383818, encodeId=f0e613838189a, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=BMC Med：用SGLT2抑制剂治疗的慢性肾病和2型糖尿病患者的心肾并发症和治疗失败的预测因素, objectType=article, longId=736106, objectId=5cc6e3610606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cc6e3610606, replyNumber=0, likeNumber=85, createdTime=2022-08-19, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cc6e3610606, moduleTitle=BMC Med：用SGLT2抑制剂治疗的慢性肾病和2型糖尿病患者的心肾并发症和治疗失败的预测因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5cc6e3610606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383815, encodeId=d29c138381565, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=磺脲类药物可增加2型糖尿病患者的癌症风险？最新研究答案是“No”！, objectType=article, longId=735644, objectId=a962e3564404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a962e3564404, replyNumber=0, likeNumber=110, createdTime=2022-08-13, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a962e3564404, moduleTitle=磺脲类药物可增加2型糖尿病患者的癌症风险？最新研究答案是“No”！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a962e3564404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383817, encodeId=a819138381ee9, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险, objectType=article, longId=735642, objectId=ed39e3564211, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed39e3564211, replyNumber=0, likeNumber=99, createdTime=2022-08-13, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed39e3564211, moduleTitle=Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ed39e3564211)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383814, encodeId=0d77138381407, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Front Endocrinol：磺脲类降糖药与2型糖尿病患者的患癌风险, objectType=article, longId=735608, objectId=e93ee35608c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93ee35608c6, replyNumber=0, likeNumber=90, createdTime=2022-08-12, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93ee35608c6, moduleTitle=Front Endocrinol：磺脲类降糖药与2型糖尿病患者的患癌风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e93ee35608c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383816, encodeId=3b471383816e0, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响, objectType=article, longId=735307, objectId=2702e353073e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2702e353073e, replyNumber=0, likeNumber=116, createdTime=2022-08-10, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2702e353073e, moduleTitle=PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2702e353073e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383813, encodeId=9b76138381326, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=格列美脲可改善2型糖尿病患者非酒精性脂肪肝及相关代谢, objectType=article, longId=734020, objectId=d5bfe340206c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5bfe340206c, replyNumber=0, likeNumber=82, createdTime=2022-08-01, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5bfe340206c, moduleTitle=格列美脲可改善2型糖尿病患者非酒精性脂肪肝及相关代谢, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d5bfe340206c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383810, encodeId=1aba1383810e3, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardoovasc Diabetol:格列美脲对2型糖尿病患者血糖控制以外的可能影响, objectType=article, longId=733951, objectId=2a74e33951db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a74e33951db, replyNumber=0, likeNumber=84, createdTime=2022-07-31, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a74e33951db, moduleTitle=Cardoovasc Diabetol:格列美脲对2型糖尿病患者血糖控制以外的可能影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2a74e33951db)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

2型糖尿病患者

2020-05-29

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#2型糖尿病患者#平稳控制血糖，减少并发症的发生

2023-06-19

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#2型糖尿病患者#糖尿病，饮食，药物，

2023-06-17

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#2型糖尿病患者#学习

2023-05-08

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#2型糖尿病患者#糖尿病，运动，药物，饮食

2023-03-06

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Front Immunol：使用格列汀降低大疱性类天疱疮和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗体

2022-09-17

一叶知秋 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：2型糖尿病患者累积甘油三酯-葡萄糖指数与主要心血管不良事件的相关性

2022-09-15

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良

2022-09-15

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DRCP：格列美脲/二甲双胍固定联合剂与单药治疗2型糖尿病患者的比较研究

2022-09-12

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Radiology：这些全自动腹部CT指标，实现了2型糖尿病患者的超早期诊断！

2022-09-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Front Immunol：维生素D补充剂调节2型糖尿病患者血小板介导的炎症

2022-08-25

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Acta Diabetol：降糖药与初级保健的2型糖尿病患者卒中和短暂性脑缺血发作的相关性

2022-08-25

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Front Pharmacol：2型糖尿病患者使用DPP-4i、GLP-1 RAs和SGLT-2i的骨折风险

2022-08-25

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究

2022-08-23

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

BMC Med：用SGLT2抑制剂治疗的慢性肾病和2型糖尿病患者的心肾并发症和治疗失败的预测因素

2022-08-19

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

磺脲类药物可增加2型糖尿病患者的癌症风险？最新研究答案是“No”！

2022-08-13

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险

2022-08-13

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Front Endocrinol：磺脲类降糖药与2型糖尿病患者的患癌风险

2022-08-12

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响

2022-08-10

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

格列美脲可改善2型糖尿病患者非酒精性脂肪肝及相关代谢

2022-08-01

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardoovasc Diabetol:格列美脲对2型糖尿病患者血糖控制以外的可能影响

2022-07-31

科室
- - 订阅+
  - 更多科室
工具
服务